Yayın:
Surface modification of PLGA nanoparticles with chitosan or Eudragit® RS 100: Characterization, prolonged release, cytotoxicity, and enhanced antimicrobial activity

dc.contributor.authorKırımlıoğlu, Gülsel Yurtdaş
dc.contributor.authorGörgülü, Şennur
dc.contributor.orcid0000-0001-8897-0885
dc.contributor.orcid0000-0003-2026-2924
dc.date.accessioned2025-11-13T09:40:59Z
dc.date.issued2020-10-21
dc.identifier.doihttps://doi.org/10.1016/j.jddst.2020.102145
dc.identifier.endpage102145
dc.identifier.issn1773-2247
dc.identifier.openalexW3093948233
dc.identifier.startpage102145
dc.identifier.urihttps://hdl.handle.net/11421/1869
dc.identifier.urihttps://doi.org/10.1016/j.jddst.2020.102145
dc.identifier.volume61
dc.language.isoen
dc.relation.ispartofJournal of Drug Delivery Science and Technology
dc.rightsrestrictedAccess
dc.subjectZeta potential
dc.subjectChitosan
dc.subjectPLGA
dc.subjectAntimicrobial
dc.subjectBiocompatibility
dc.subjectNuclear chemistry
dc.subjectSurface modification
dc.subjectBioavailability
dc.subjectAntibacterial activity
dc.subjectChemistry
dc.subjectCationic polymerization
dc.subjectNanoparticle
dc.subjectMaterials science
dc.subjectNanotechnology
dc.subjectOrganic chemistry
dc.subjectBacteria
dc.subjectPharmacology
dc.subjectMedicine
dc.titleSurface modification of PLGA nanoparticles with chitosan or Eudragit® RS 100: Characterization, prolonged release, cytotoxicity, and enhanced antimicrobial activity
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5030894826
local.authorid.openalexA5080219288

Dosyalar

Koleksiyonlar